Vascular cell senescence and vascular aging

Journal of Molecular and Cellular Cardiology

Volumn 36, Issue 2, 2004, Pages 175-183

  Minamino, Tohru ^a   Miyauchi, Hideyuki ^a   Yoshida, Toshihiko ^a   Tateno, Kaoru ^a   Kunieda, Takeshige ^a   Komuro, Issei ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Aging; Akt; Atherosclerosis; Cyclin dependent kinase inhibitor; Inflammation; Ras; Senescence; Telomere

Indexed keywords

ONCOPROTEIN; PROTEIN P53; RAS PROTEIN; TELOMERASE; TUMOR SUPPRESSOR PROTEIN;

CARDIOVASCULAR SYSTEM; CELL AGING; GENETIC MODEL; HUMAN; IN VIVO STUDY; INFLAMMATION; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; TELOMERE; VASCULAR DISEASE; VASCULARIZATION;

ANIMALIA;

EID: 1042298050     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2003.11.010     Document Type: Review

References (112)

1. Faragher R.G., Kipling D. How might replicative senescence contribute to human ageing? Bioessays. 20:1998;985-991.
2. Hayflick L. Current theories of biological aging. Fed Proc. 34:1975;9-13.
3. Schneider E.L., Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc Natl Acad Sci USA. 73:1976;3584-3588.
4. Rohme D. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci USA. 78:1981;5009-5013.
5. Thompson K.V., Holliday R. Genetic effects on the longevity of cultured human fibroblasts. II. DNA repair deficient syndromes. Gerontology. 29:1983;83-88.
6. Campisi J., Kim S.H., Lim C.S., Rubio M. Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol. 36:2001;1619-1637.
7. Serrano M., Blasco M.A. Putting the stress on senescence. Curr Opin Cell Biol. 13:2001;748-753.
8. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
9. Lin A.W., Barradas M., Stone J.C., van Aelst L., Serrano M., Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:1998;3008-3019.
10. Zhu J., Woods D., McMahon M., Bishop J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:1998;2997-3007.
11. Campisi J. The biology of replicative senescence. Eur J Cancer. 33:1997;703-709.
12. Bringold F., Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol. 35:2000;317-329.
13. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 92:1995;9363-9367.
14. Kumazaki T., Kobayashi M., Mitsui Y. Enhanced expression of fibronectin during in vivo cellular aging of human vascular endothelial cells and skin fibroblasts. Exp Cell Res. 205:1993;396-402.
15. Bennett M.R., Macdonald K., Chan S.W., Boyle J.J., Weissberg P.L. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 82:1998;704-712.
16. Burrig K.F. The endothelium of advanced arteriosclerotic plaques in humans. Arterioscler Thromb. 11:1991;1678-1689.
17. Ross R., Wight T.N., Strandness E., Thiele B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 114:1984;79-93.
18. Fenton M., Barker S., Kurz D.J., Erusalimsky J.D. Cellular senescence after single and repeated balloon catheter denudations of rabbit carotid arteries. Arterioscler Thromb Vasc Biol. 21:2001;220-226.
19. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation. 105:2002;1541-1544.
20. Minamino T., Yoshida T., Tateno K., Miyauchi H., Zou Y., Toko H., et al. Ras induces vascular smooth muscle cell senescence and inflammation in human atherosclerosis. Circulation. 2003;. [in press].
21. Marin J. Age-related changes in vascular responses: a review. Mech Ageing Dev. 79:1995;71-114.
22. Rivard A., Fabre J.E., Silver M., Chen D., Murohara T., Kearney M., et al. Age-dependent impairment of angiogenesis. Circulation. 99:1999;111-120.
23. Rivard A., Berthou-Soulie L., Principe N., Kearney M., Curry C., Branellec D., et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem. 275:2000;29643-29647.
24. Schneiderman J., Sawdey M.S., Keeton M.R., Bordin G.M., Bernstein E.F., Dilley R.B., et al. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA. 89:1992;6998-7002.
25. Sato I., Morita I., Kaji K., Ikeda M., Nagao M., Murota S. Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cell. Biochem Biophys Res Commun. 195:1993;1070-1076.
26. Matsushita H., Chang E., Glassford A.J., Cooke J.P., Chiu C.P., Tsao P.S. eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ Res. 89:2001;793-798.
27. Hoffmann J., Haendeler J., Aicher A., Rossig L., Vasa M., Zeiher A.M., et al. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res. 89:2001;709-715.
28. Nakajima M., Hashimoto M., Wang F., Yamanaga K., Nakamura N., Uchida T., et al. Aging decreases the production of PGI2 in rat aortic endothelial cells. Exp Gerontol. 32:1997;685-693.
29. Comi P., Chiaramonte R., Maier J.A. Senescence-dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp Cell Res. 219:1995;304-308.
30. Maier J.A., Statuto M., Ragnotti G. Senescence stimulates U937-endothelial cell interactions. Exp Cell Res. 208:1993;270-274.
31. Yang J., Chang E., Cherry A.M., Bangs C.D., Oei Y., Bodnar A., et al. Human endothelial cell life extension by telomerase expression. J Biol Chem. 274:1999;26141-26148.
32. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:1997;964-967.
33. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 5:1999;434-438.
34. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med. 348:2003;593-600.
35. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 89:2001;E1-E7.
36. Stewart S.A., Ben-Porath I., Carey V.J., O'Connor B.F., Hahn W.C., Weinberg R.A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat Genet. 33:2003;492-496.
37. Karlseder J., Smogorzewska A., de Lange T. Senescence induced by altered telomere state, not telomere loss. Science. 295:2002;2446-2449.
38. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
39. Bryan T.M., Englezou A., Dalla-Pozza L., Dunham M.A., Reddel R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med. 3:1997;1271-1274.
40. Chang E., Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA. 92:1995;11190-11194.
41. Minamino T., Mitsialis S.A., Kourembanas S. Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol. 21:2001;3336-3342.
42. Blackburn E.H. Switching and signaling at the telomere. Cell. 106:2001;661-673.
43. Baumann P., Cech T.R. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science. 292:2001;1171-1175.
44. Hsu H.L., Gilley D., Blackburn E.H., Chen D.J. Ku is associated with the telomere in mammals. Proc Natl Acad Sci USA. 96:1999;12454-12458.
45. Broccoli D., Smogorzewska A., Chong L., de Lange T. Human telomeres contain two distinct Myb-related proteins, TRF1 and TRF2. Nat Genet. 17:1997;231-235.
46. Loayza D., De Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature. 424:2003;1013-1018.
47. Espejel S., Franco S., Rodriguez-Perales S., Bouffler S.D., Cigudosa J.C., Blasco M.A. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21:2002;2207-2219.
48. Espejel S., Franco S., Sgura A., Gae D., Bailey S.M., Taccioli G.E., et al. Functional interaction between DNA-PKCs and telomerase in telomere length maintenance. EMBO J. 21:2002;6275-6287.
49. Wong K.K., Maser R.S., Bachoo R.M., Menon J., Carrasco D.R., Gu Y., et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature. 421:2003;643-648.
50. Griffith J.D., Comeau L., Rosenfield S., Stansel R.M., Bianchi A., Moss H., et al. Mammalian telomeres end in a large duplex loop. Cell. 97:1999;503-514.
51. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell. 92:1998;401-413.
52. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21:2002;4338-4348.
53. Baur J.A., Zou Y., Shay J.W., Wright W.E. Telomere position effect in human cells. Science. 292:2001;2075-2077.
54. Minamino T., Komuro I. Role of telomere in endothelial dysfunction in atherosclerosis. Curr Opin Lipidol. 13:2002;537-543.
55. Karlseder J., Broccoli D., Dai Y., Hardy S., de Lange T. p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science. 283:1999;1321-1325.
56. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 91:1997;25-34.
57. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W. II, Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature. 392:1998;569-574.
58. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell. 96:1999;701-712.
59. Franco S., Segura I., Riese H.H., Blasco M.A., Decreased B. Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres. Cancer Res. 62:2002;552-559.
60. Leri A., Franco S., Zacheo A., Barlucchi L., Chimenti S., Limana F., et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 22:2003;131-139.
61. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
62. Lin S.Y., Elledge S.J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell. 113:2003;881-889.
63. Smith L.L., Coller H.A., Roberts J.M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol. 5:2003;474-479.
64. Minamino T., Kourembanas S. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ Res. 89:2001;237-243.
65. Hsiao R., Sharma H.W., Ramakrishnan S., Keith E., Narayanan R. Telomerase activity in normal human endothelial cells. Anticancer Res. 17:1997;827-832.
66. Yang J., Nagavarapu U., Relloma K., Sjaastad M.D., Moss W.C., Passaniti A., et al. Telomerized human microvasculature is functional in vivo. Nat Biotechnol. 19:2001;219-224.
67. Dimri G.P., Itahana K., Acosta M., Campisi J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol Cell Biol. 20:2000;273-285.
68. Wang W., Chen J.X., Liao R., Deng Q., Zhou J.J., Huang S., et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol. 22:2002;3389-3403.
69. Sherr C.J. Tumor surveillance via the ARF-p53 pathway. Gene Dev. 12:1998;2984-2991.
70. Palmero I., Pantoja C., Serrano M. p19ARF links the tumour suppressor p53 to Ras. Nature. 395:1998;125-126.
71. Jacobs J.J., Keblusek P., Robanus-Maandag E., Kristel P., Lingbeek M., Nederlof P.M., et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet. 26:2000;291-299.
72. Ferbeyre G., de Stanchina E., Querido E., Baptiste N., Prives C., Lowe S.W. PML is induced by oncogenic ras and promotes premature senescence. Gene Dev. 14:2000;2015-2027.
73. Pearson M., Carbone R., Sebastiani C., Cioce M., Fagioli M., Saito S., et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 406:2000;207-210.
74. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 97:1999;527-538.
75. Burkhart B.A., Alcorta D.A., Chiao C., Isaacs J.S., Barrett J.C. Two posttranscriptional pathways that regulate p21(Cip1/Waf1/Sdi1) are identified by HPV16-E6 interaction and correlate with life span and cellular senescence. Exp Cell Res. 247:1999;168-175.
76. Ohtani N., Zebedee Z., Huot T.J., Stinson J.A., Sugimoto M., Ohashi Y., et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 409:2001;1067-1070.
77. McConnell B.B., Starborg M., Brookes S., Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol. 8:1998;351-354.
78. Ihling C., Menzel G., Wellens E., Monting J.S., Schaefer H.E., Zeiher A.M. Topographical association between the cyclin-dependent kinases inhibitor p21, p53 accumulation, and cellular proliferation in human atherosclerotic tissue. Arterioscler Thromb Vasc Biol. 17:1997;2218-2224.
79. Guevara N.V., Kim H.S., Antonova E.I., Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 5:1999;335-339.
80. von der Thusen J.H., van Vlijmen B.J., Hoeben R.C., Kockx M.M., Havekes L.M., van Berkel T.J., et al. Induction of atherosclerotic plaque rupture in apolipoprotein E-/-mice after adenovirus-mediated transfer of p53. Circulation. 105:2002;2064-2070.
81. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
82. Indolfi C., Avvedimento E.V., Rapacciuolo A., Di Lorenzo E., Esposito G., Stabile E., et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med. 1:1995;541-545.
83. George J., Afek A., Keren P., Herz I., Goldberg I., Haklai R., et al. Functional inhibition of Ras by S-trans, trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice. Circulation. 105:2002;2416-2422.
84. Brasier A.R., Recinos A. III, Eledrisi M.S. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 22:2002;1257-1266.
85. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 105:2002;1135-1143.
86. Guarente L., Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature. 408:2000;255-262.
87. Kenyon C. A conserved regulatory system for aging. Cell. 105:2001;165-168.
88. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 366:1993;461-464.
89. Lee R.Y., Hench J., Ruvkun G. Regulation of C. elegans DAF-16 and its human ortholog FKHRL1 by the daf-2 insulin-like signaling pathway. Curr Biol. 11:2001;1950-1957.
90. Lin K., Hsin H., Libina N., Kenyon C. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet. 28:2001;139-145.
91. Longo V.D., Finch C.E. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science. 299:2003;1342-1346.
92. Morris J.Z., Tissenbaum H.A., Ruvkun G. A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature. 382:1996;536-539.
93. Ogg S., Paradis S., Gottlieb S., Patterson G.I., Lee L., Tissenbaum H.A., et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature. 389:1997;994-999.
94. Lin K., Dorman J.B., Rodan A., Kenyon C. daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science. 278:1997;1319-1322.
95. Fabrizio P., Pozza F., Pletcher S.D., Gendron C.M., Longo V.D. Regulation of longevity and stress resistance by Sch9 in yeast. Science. 292:2001;288-290.
96. Tatar M., Kopelman A., Epstein D., Tu M.P., Yin C.M., Garofalo R.S. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science. 292:2001;107-110.
97. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 421:2003;182-187.
98. Bluher M., Kahn B.B., Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science. 299:2003;572-574.
99. Fabrizio P., Liou L.L., Moy V.N., Diaspro A., SelverstoneValentine J., Gralla E.B., et al. SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics. 163:2003;35-46.
100. Honda Y., Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J. 13:1999;1385-1393.
101. Murphy C.T., McCarroll S.A., Bargmann C.I., Fraser A., Kamath R.S., Ahringer J., et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 424:2003;277-283.
102. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
103. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature. 411:2001;355-365.
104. Testa J.R., Bellacosa A. AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA. 98:2001;10983-10985.
105. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B. III, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 292:2001;1728-1731.
106. Vogel H., Lim D.S., Karsenty G., Finegold M., Hasty P. Deletion of Ku86 causes early onset of senescence in mice. Proc Natl Acad Sci USA. 96:1999;10770-10775.
107. de Boer J., Andressoo J.O., de Wit J., Huijmans J., Beems R.B., van Steeg H., et al. Premature aging in mice deficient in DNA repair and transcription. Science. 296:2002;1276-1279.
108. Cao L., Li W., Kim S., Brodie S.G., Deng C.X. Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Gene Dev. 17:2003;201-213.
109. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., et al. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53.
110. Edelberg J.M., Tang L., Hattori K., Lyden D., Rafii S. Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res. 90:2002;E89-E93.
111. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., Wang T., Gregg D., Ramaswami P., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation. 108:2003;457-463.
112. Murasawa S., Llevadot J., Silver M., Isner J.M., Losordo D.W., Asahara T. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation. 106:2002;1133-1139.